Back
Protagonist Therapeutics Stock Price Chart
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
47.64
Seasonality Move:
13.55%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!
Don't miss out-click here for urgent details on the #1 gold play of the year!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.87 | Buy |
| 20-day SMA: | 45.2 | Buy |
| 50-day SMA: | 43.19 | Buy |
| 200-day SMA: | 33.03 | Buy |
| 8-day EMA: | 45.46 | Buy |
| 20-day EMA: | 44.91 | Buy |
| 50-day EMA: | 42.95 | Buy |
| 200-day EMA: | 34.35 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 65.65 | Buy |
| Chaikin Money Flow: | 126936 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.19 - 46.41) | Buy |
| Bollinger Bands (100): | (33.39 - 44.11) | Buy |
Protagonist Therapeutics Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 47.64 while PTGX 8-day simple moving average is 44.87, which is a Buy signal.
- The stock price of PTGX is 47.64 while Protagonist Therapeutics 20-day SMA is 45.20, which makes it a Buy.
- Protagonist Therapeutics 50-day simple moving average is 43.19 while PTGX share price is 47.64, making it a Buy technically.
- PTGX stock price is 47.64 and Protagonist Therapeutics 200-day simple moving average is 33.03, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Buy
The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.81B
Price in USD:
47.64
Share Volume:
598.54K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.32
52-Week Low:
13.72
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 47.64 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is not overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 47.64 while PTGX 8-day exponential moving average is 45.46, which is a Buy signal.
- The stock price of PTGX is 47.64 while Protagonist Therapeutics 20-day EMA is 44.91, which makes it a Buy.
- Protagonist Therapeutics 50-day exponential moving average is 42.95 while PTGX share price is 47.64, making it a Buy technically.
- PTGX stock price is 47.64 and Protagonist Therapeutics 200-day simple moving average is 34.35, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is 0.62, suggesting Protagonist Therapeutics is a Buy
- Protagonist Therapeutics Relative Strength Index (RSI) is 65.65, which suggest Protagonist Therapeutics is overbought
- The Bollinger Bands (25) for Protagonist Therapeutics is (44.19 - 46.41), which suggest Protagonist Therapeutics is a Buy
- The Bollinger Bands (100) for Protagonist Therapeutics is (33.39 - 44.11), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.